Related references
Note: Only part of the references are listed.Role of the Low-Affinity Leukotriene B4 Receptor BLT2 in VEGF-Induced Angiogenesis
Geun-Young Kim et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation
R. Hennig et al.
BRITISH JOURNAL OF CANCER (2008)
Reactive oxygen species are generated through a BLT2-linked cascade in Ras-transformed cells
Jung-A Choi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Lipoxygenase pathway receptor expression in ovarian cancer
Rodney P. Rocconi et al.
REPRODUCTIVE SCIENCES (2008)
Cyclooxygenases, prostanoids, and tumor progression
Man-Tzu Wang et al.
CANCER AND METASTASIS REVIEWS (2007)
Activation and regulation of cellular eicosanoid biosynthesis
Thomas G. Brock et al.
THESCIENTIFICWORLDJOURNAL (2007)
The signaling mechanism of ROS in tumor progression
Wen-Sheng Wu
CANCER AND METASTASIS REVIEWS (2006)
H-Ras selectively up-regulates MMP-9 and COX-2 through activation of ERK1/2 and NF-κB:: An implication for invasive phenotype in rat liver epithelial cells
Ki Won Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis
Eun Ha Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor
RD Bonfil et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Differential induction of BLT receptor expression on human endothelial cells by lipopolysacharide, cytokines, and leukotriene B4
H Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Impact of polyunsaturated fatty acids on hepato-pancreatic prostaglandin and leukotriene concentration in ductal pancreatic cancer - Is there a correlation to tumour growth and liver metastasis?
I Heukamp et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma
J Nikkola et al.
CLINICAL CANCER RESEARCH (2005)
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia
ZZ Gu et al.
JOURNAL OF NEUROSCIENCE (2005)
Characterization of a mouse second leukotriene b4 receptor, mBLT2 - BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes
Y Iizuka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-κB signaling pathways
A Zampetaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
A novel anti-pancreatic cancer agent LY293111
XZ Ding et al.
ANTI-CANCER DRUGS (2005)
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor
A Krüger et al.
CANCER RESEARCH (2005)
Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells
R Mayoral et al.
CARCINOGENESIS (2005)
LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice
R Hennig et al.
NEOPLASIA (2005)
Oncogenic Ras in tumour progression and metastasis
K Giehl
BIOLOGICAL CHEMISTRY (2005)
Oncogenic Ras and its role in tumor cell invasion and metastasis
PM Campbell et al.
SEMINARS IN CANCER BIOLOGY (2004)
Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention
KS Chun et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy
M Romano et al.
FASEB JOURNAL (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Metastasis is driven by sequential elevation of H-ras and Smad2 levels
M Oft et al.
NATURE CELL BIOLOGY (2002)
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer - Evidence for involvement of AP-1 and PEA3
K Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Leukotriene B4 stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis
CH Woo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of eicosanoids in prostate cancer progression
DT Nie et al.
CANCER AND METASTASIS REVIEWS (2001)
v-Ha-RaS oncogene upregulates the 92-kDA type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-κB
JQ Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Role of the cytosolic phospholipase A2-linked cascade in signaling by an oncogenic, constitutively active Ha-Ras isoform
MH Yoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2
T Yokomizo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells
V Van Putten et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A second leukotriene B4 receptor, BLT2:: A new therapeutic target in inflammation and immunological disorders
T Yokomizo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Activator protein 1 (AP-1)- and nuclear factor κB (NF-κB)-dependent transcriptional events in carcinogenesis
TC Hsu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
